V. Michael Holers
Director/Board Member at Q32 Bio, Inc.
Profile
V.
Michael Holers was the founder of Taligen Therapeutics, Inc. (founded in 2004) where he held the title of Director & Chief Scientific Officer from 2010 to 2012.
He currently holds positions at American College of Rheumatology Research & Education Fdn as Director-at-Large since 2010, at Q32 Bio, Inc. as Secretary & Director, and at The University of Colorado as a Professor.
He previously worked at American College of Rheumatology as a Director and at Washington University in St. Louis as a Professor.
Dr. Holers received a doctorate degree from Washington University in St. Louis and an undergraduate degree from Purdue University.
V. Michael Holers active positions
| Companies | Position | Start |
|---|---|---|
| The University of Colorado | Corporate Officer/Principal | - |
American College of Rheumatology Research & Education Fdn
 American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | Director/Board Member | 2010-11-16 |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of V. Michael Holers
| Companies | Position | End |
|---|---|---|
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Founder | 2012-02-23 |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Director/Board Member | - |
| Washington University in St. Louis | Corporate Officer/Principal | - |
Training of V. Michael Holers
| Washington University in St. Louis | Doctorate Degree |
| Purdue University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Health Technology |
American College of Rheumatology
American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services The American College of Rheumatology is an organization for physicians and health professionals. The non-profit company is based in Atlanta, GA. The company was founded by Göran Albert Torstensson Ando. | Commercial Services |
American College of Rheumatology Research & Education Fdn
American College of Rheumatology Research & Education Fdn Investment Trusts/Mutual FundsMiscellaneous The American College of Rheumatology Research and Education Foundation was established in 1985 with a mission of advancing research and training to improve the health of people with rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatology by funding research, training and education opportunities for clinicians, students, health professionals, researchers and academic institutions. | Miscellaneous |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- V. Michael Holers